By Jennifer Rigby and Richa Naidu LONDON (Reuters) - (This June 29 story has been corrected to drop the reference to aspartame being removed from PepsiCo products in 2020, in paragraph 25. A PepsiCo spokesperson corrected an earlier statement from…
By Rachel Nostrant (Reuters) - Nearly half of U.S. tap water samples contain toxic "forever chemicals," substances used in hundreds of household items from cleaning supplies to pizza boxes to which broad exposure can carry serious health risks, according to…
By Emma Farge GENEVA (Reuters) - Nadine, a social robot powered by Artificial Intelligence (AI) with human-like gestures and expressions, could have an important future role to play in tending to the sick and elderly, according to a professor who…
By Nathan Gomes (Reuters) -The U.S. Food and Drug Administration on Thursday approved BioMarin Pharmaceutical's gene therapy for severe hemophilia A, the company said, giving patients with the inherited bleeding disorder an alternative to regular injections of missing blood proteins.…
By Sarah N. Lynch WASHINGTON (Reuters) -The U.S. Justice Department on Wednesday announced federal and local criminal charges targeting 78 defendants across 16 states as part of a law enforcement action involving $2.5 billion in alleged healthcare fraud schemes targeting…
By Leroy Leo and Aditya Samal (Reuters) - The U.S. health regulator has granted accelerated approval to Sarepta Therapeutics' first-of-its-kind gene therapy for Duchenne muscular dystrophy (DMD), an inherited progressive muscle-wasting disorder that almost always affects young boys. Sarepta said…
By Nate Raymond (Reuters) -The U.S. Supreme Court on Friday preserved the Justice Department's power to unilaterally dismiss lawsuits filed under a law that lets whistleblowers sue businesses on behalf of the government to recover taxpayer money paid to companies…
By Julie Steenhuysen and Michael Erman (Reuters) - The U.S. Food and Drug Administration said on Friday it is seeking new suppliers to ease shortages of methotrexate, one of the most commonly used cancer drugs, building on its push to…
By Rachael Levy, Krystal Hu and Marisa Taylor (Reuters) - Elon Musk's brain implant startup Neuralink, which was valued at close to $2 billion in a private fundraising round two years ago, is now worth around $5 billion based on…
(Reuters) -Cancer test maker Grail Inc said on Friday that its telemedicine vendor erroneously sent letters to about 400 patients suggesting they may have developed cancer. Grail's flagship cancer detection blood test Galleri is designed to detect more than 50…